07-0019 Biotechnolog 54 Professional, Scientific, and Technical Services

The ECPC received 22 separate responses requesting the creation of new industries for medical biotechnology products, food

and agricultural biotechnology products, and industrial biotechnology products. The proposals were assigned docket

numbers: 07-0013, 07-0014, 07-0015, 07-0016, 07-0018, 07-0019, 07-0020, 07-0022, 07-0023, 07-0024, 07-0025, 07-0026,

07-0027, 07-0028, 07-0029, 07-0030, 07-0031, 07-0036, 07-0037, 07-0041, 07-0044, and 07-0049. The proposals did not

contain information regarding the size of the potential industries, importance of the industries in Canada or Mexico, or any

information regarding the separate production function justification for creating the new industries. In order to evaluate the

proposals, the ECPC consulted with an industry trade association to clarify the requests for new industries.


The ECPC clarified the requests as proposals to create industries for establishments that use biotechnology inputs, use

biotechnology processes, or produce biotechnology outputs. The practical impact of these proposals would be to group

establishments that are currently classified in the Agriculture; Manufacturing; and Professional, Scientific and Technical

Services sectors of NAICS.


The ECPC used the principles of NAICS to evaluate these requests. The ECPC recommends against creating the three

industries requested based on the mixture of production processes that would be involved. These activities are currently

classified throughout the NAICS system. For example, growing genetically modified crops is in farming, production of biotech

enzymes is in the chemicals subsector of NAICS, and manufacturing foods from biotech inputs is classified in food

manufacturing. The ECPC considered the production processes and similarities to other production processes already

separately identified in NAICS. Growing a genetically modified crop may require a different production function from the

growing of a more traditional version of the crop because of decreased need for pesticides or other inputs. The production

process is still closer to other agriculture production processes than it is to manufacturing production processes or

professional service production processes. A similar rationale applies to food manufacturing production processes,

pharmaceutical manufacturing production processes, and industrial manufacturing production processes.


The ECPC recognized the importance of biotechnology as an emerging technology that should be accounted for in NAICS.

While recommending against the proposals received in response to the Federal Register notice, the ECPC does recommend

creation of a new industry for Biotechnology Research and Development. This industry will contain units that are using

biotechnology processes to develop general knowledge and to develop new products and processes using biotechnology.

The new biotechnology research and development industry is in conformance with the principles of NAICS: 1) the new

industry will group similar establishments using biotechnology processes in experimental research and development; 2) the

new industry addresses a new and emerging activity resulting in the production of advanced technologies; and 3) is expected

to be comparable with a new biotechnology research and development industry proposed in the on-going revision of the

International Standard Industrial Classification of All Economic Activities, ISIC, of the United Nations. In order to minimize time

series disruptions, splitting NAICS 541710, Research and Development in the Physical, Engineering, and Life Sciences, into two

portions will create the new industry. The two parts can be reaggregated to match the previous industry detail in NAICS

United States 1997 and NAICS United States 2002. The ECPC proposes the following structure:



54171 Research and Development in the Physical, Engineering, and Life Sciences

541711 Biotechnology Research and Development

541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)


The ECPC also reviewed the results of a biotechnology use survey performed by the Department of Commerce and reviewed

preliminary survey results regarding biotechnology research and development from the 2002 Economic Census. Both sources

indicate that the proposed industry will be supportable in collection and publication. The ECPC recommends that the

respondents work with statistical data collection programs in order to ensure that adequate biotechnology product detail is

included in future data collection efforts.
First Previous Next Last